Familial hyperkalemic hypertension

Journal of the American Society of Nephrology

Volumn 17, Issue 1, 2006, Pages 208-217

  Hadchouel, Juliette ^a,b,c,d   Delaloy, Céline ^a,b,c,d   Fauré, Sébastien ^e   Achard, Jean Michel ^e   Jeunemaitre, Xavier ^a,b,c,d  

^a l'alimentation et l'Environnement   (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; WNK KINASE;

CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE SEVERITY; FAMILIAL HYPERKALEMIC HYPERTENSION SYNDROME; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC TRAIT; GENOTYPE; GLOMERULUS FILTRATION RATE; GORDON SYNDROME; HUMAN; HYPERKALEMIA; HYPERTENSION; INHERITANCE; METABOLIC ACIDOSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; WNK1 GENE; WNK4 GENE;

EID: 33645379951     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005030314     Document Type: Review

References (59)

1. Paver W, Pauline G: Hypertension and hyperpotassaemia without renal disease in a young male. Med J Aust 2: 305-306, 1964
2. Arnold JE, Healy JK: Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med 47: 461-472, 1969
3. Gordon RD: The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome. Aust N Z J Med 16: 183-184, 1986
4. Schambelan M, Sebastian A, Rector FJ: Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption. Kidney Int 19: 716-727, 1981
5. Gordon R, Klemm S, Tunny T: Gordon's syndrome: A sodium-volume-dependent form of hypertension with a genetic basis. In: Hypertension: Pathology, Diagnosis and Management, edited by Laragh J, Brenner B, New York, Raven Press Ltd., 1995 pp 32111-32211
6. Disse-Nicodeme S, Achard JM, Potier J, Delahousse M, Fiquet-Kempf B, Stern N, Blanchard A, Guilbaud JC, Niaudet P, Chauveau D, Dussol B, Berland Y, Dequiedt P, Ader JL, Paillard M, Grunfeld JP, Fournier A, Corvol P, Jeunemaitre X: Familial hyperkalemic hypertension (Gordon syndrome): Evidence for phenotypic variability in a study of 7 families. Adv Nephrol Necker Hosp 31: 55-68, 2001
7. Stokes G, Gentle J, Edwards K, Stewart J: Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: Effects on plasma renin and aldosterone of reducing the serum potassium level. Med J Aust 2: 1050-1054, 1968
8. Gordon RD, Geddes RA, Pawsey CGK, Halorau MW: Hypertension and severe hyperkalemia associated with suppression of renin and aldosterone, and completely reversed by dietary sodium restriction. Aust Ann Med 4: 187-194, 1970
9. Sanjad S, Mansour F, Hernandez R, Hill L: Severe hypertension, hyperkalemia, and renal tubular acidosis responding to dietary sodium restriction. Pediatrics 69: 317-324, 1982
10. Brautbar N, Levi J, Rosler A, Leitesdorf E, Djaldeti M, Epstein M, Kleeman CR: Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling. Arch Intern Med 138: 607-610, 1978
11. Achard JM, Warnock DG, Disse-Nicodeme S, Fiquet-Kempf B, Corvol P, Fournier A, Jeunemaitre X: Familial hyperkalemic hypertension: Phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med 114: 495-498, 2003
12. Simon D, Farfel Z, Ellison D, Bia M, Tucci J, Lifton RP: Examination of the thiazide-sensitive Na-Cl cotransporter as a candidate gene in Gordon's syndrome. J Am Soc Nephrol 6: 632, 1995
13. Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP: Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 16: 202-205, 1997
14. Disse-Nicodeme S, Achard JM, Desitter I, Houot AM, Fournier A, Corvol P, Jeunemaitre X: A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet 67: 302-310, 2000
15. Disse-Nicodeme S, Desitter I, Fiquet-Kempf B, Houot AM, Stern N, Delahousse M, Potier J, Ader JL, Jeunemaitre X: Genetic heterogeneity of familial hyperkalaemic hypertension. J Hypertens 19: 1957-1964, 2001
16. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP: Human hypertension caused by mutations in WNK kinases. Science 293: 1107-1112, 2001
17. Golbang AP, Murthy M, Hamad A, Liu CH, Cope G, Hoff WV, Cuthbert A, O'Shaughnessy KM: A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. Hypertension 46: 295-300, 2005
18. Abe MK, Kahle KT, Saelzler MP, Orth K, Dixon JE, Rosner MR: ERK7 is an autoactivated member of the MAPK family. J Biol Chem 276: 21272-21279, 2001
19. Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH: WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 275: 16795-16801, 2000
20. Verissimo F, Jordan P: WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20: 5562-5569, 2001
21. Holden S, Cox J, Raymond FL: Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 (PRKWNK3). Gene 335: 109-119, 2004
22. Min X, Lee BH, Cobb MH, Goldsmith EJ: Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure (Camb) 12: 1303-1311, 2004
23. Xu BE, Min X, Stippec S, Lee BH, Goldsmith EJ, Cobb MH: Regulation of WNK1 by an autoinhibitory domain and autophosphorylation. J Biol Chem 277: 48456-48462, 2002
24. Lenertz LY, Lee BH, Min X, Xu BE, Wedin K, Earnest S, Goldsmith EJ, Cobb MH: Properties of WNK1 and implications for other family members. J Biol Chem 280: 26653-26658, 2005
25. Wang Z, Yang CL, Ellison DH: Comparison of WNK4 and WNK1 kinase and inhibiting activities. Biochem Biophys Res Commun 317: 939-944, 2004
26. Xu BE, Stippec S, Lenertz L, Lee BH, Zhang W, Lee YK, Cobb MH: WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J Biol Chem 279: 7826-7831, 2004
27. Jiang ZY, Zhou QL, Holik J, Patel S, Leszyk J, Coleman K, Chouinard M, Czech MP: Identification of WNK1 as a substrate of Akt/Protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells. J Biol Chem 280: 21622-21628, 2005
28. Lee BH, Min X, Heise CJ, Xu BE, Chen S, Shu H, Luby-Phelps K, Goldsmith EJ, Cobb MH: WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding. Mol Cell 15: 741-751, 2004
29. Chapman ER: Synaptotagmin: A Ca(2+) sensor that triggers exocytosis? Nat Rev Mol Cell Biol 3: 498-508, 2002
30. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP: Molecular pathogenesis of inherited hypertension with hyperkalemia: The Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 100: 680-684, 2003
31. Choate KA, Kahle KT, Wilson FH, Nelson-Williams C, Lifton RP: WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl(-)-transporting epithelia. Proc Natl Acad Sci U S A 100: 663-668, 2003
32. Delaloy C, Lu J, Houot AM, Disse-Nicodeme S, Gasc JM, Corvol P, Jeunemaitre X: Multiple promoters in the WNK1 gene: One controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol 23: 9208-9221, 2003
33. O'Reilly M, Marshall E, Speirs HJ, Brown RW: WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J Am Soc Nephrol 14: 2447-2456, 2003
34. Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, Forbush B, Aronson PS, Lifton RP: WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia. Proc Natl Acad Sci U S A 101: 2064-2069, 2004
35. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S, Uchida S: Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci U S A 101: 4690-4694, 2004
36. Kahle KT, Macgregor GG, Wilson FH, Van Hoek AN, Brown D, Ardito T, Kashgarian M, Giebisch G, Hebert SC, Boulpaep EL, Lifton RP: Paracellular Cl- permeability is regulated by WNK4 kinase: Insight into normal physiology and hypertension. Proc Natl Acad Sci U S A 101: 14877-14882, 2004
37. Kahle KT, Wilson FH, Leng Q, Lalioti MD, O'Connell AD, Dong K, Rapson AK, MacGregor GG, Giebisch G, Hebert SC, Lifton RP: WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 35: 372-376, 2003
38. Peng JB, Jiang Y, Warnock DG: WNK4 kinase enhances ECaC-mediated calcium transport [Abstract]. J Am Soc Nephrol 15: 62A, 2004
39. Yang CL, Zhu X, Wang Z, Subramanya AR, Ellison DH: Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 115: 1379-1387, 2005
40. Naray-Fejes-Toth A, Snyder PM, Fejes-Toth G: The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport. Proc Natl Acad Sci U S A 101: 17434-17439, 2004
41. Farfel Z, Mayan H, Yaacov Y, Mouallem M, Shaharabany M, Pauzner R, Kerem E, Wilschanski M: WNK4 regulates airway Na+ transport: Study of familial hyperkalaemia and hypertension. Eur J Clin Invest 35: 410-415, 2005
42. Xu B, Stippec S, Chu PY, Lazrak A, Li XJ, Lee BH, English JM, Ortega B, Huang CL, Cobb MH: WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci U S A 102: 10315-10320, 2005
43. Yang CL, Angell J, Mitchell R, Ellison DH: WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039-1045, 2003
44. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van Sligtenhorst I, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT: Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci U S A 100: 14109-14114, 2003
45. Gordon RD, Hodsman GP: The syndrome of hypertension and hyperkalaemia without renal failure: Long term correction by thiazide diuretic. Scott Med J 31: 43-44, 1986
46. Meneton P, Loffing J, Warnock DG: Sodium and potassium handling by the aldosterone-sensitive distal nephron: The pivotal role of the distal and connecting tubule. Am J Physiol Renal Physiol 287: F593-F601, 2004
47. Yang SS, Yamauchi K, Rai T, Hiyama A, Sohara E, Suzuki T, Itoh T, Suda S, Sasaki S, Uchida S: Regulation of apical localization of the thiazide-sensitive NaCl cotransporter by WNK4 in polarized epithelial cells. Biochem Biophys Res Commun 330: 410-414, 2005
48. Lalioti M, Kahle KT, Toka H, Nelson-Williams C, Zhang J, Lu Y, Lifton RP: Mutant WNK4 in mouse reveals mechanisms of pseudohypoaldosteronism type II [Abstract]. J Am Soc Nephrol 15: 666A, 2004
49. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z: Pseudohypoaldosteronism type II: Marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87: 3248-3254, 2002
50. Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, Holtzman EJ, Farfel Z: Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: Description of a large family with the Q565E WNK4 mutation. J Clin Endocrinol Metab 89: 4025-4030, 2004
51. Mayan H, Mouallem M, Shaharabany M, Pauzner R, Farfel Z: Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation. Am J Obstet Gynecol 192: 598-603, 2005
52. Rossier BC: Negative regulators of sodium transport in the kidney: Key factors in understanding salt-sensitive hypertension? J Clin Invest 111: 947-950, 2003
53. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S, et al: Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 353: 521-529, 1991
54. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH: Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 36: 477-483, 2000
55. Julier C, Delepine M, Keavney B, Terwilliger J, Davis S, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P, Ratcliffe P, Corvol P, Soubrier F, Lathrop GM: Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet 6: 2077-2085, 1997
56. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB: Genetics of essential hypertension. Hum Mol Genet 13(Spec No 1): R169-R175, 2004
57. Monti J, Zimdahl H, Schulz H, Plehm R, Ganten D, Hubner N: The role of Wnk4 in polygenic hypertension: A candidate gene analysis on rat chromosome 10. Hypertension 41: 938-942, 2003
58. Erlich PM, Cui J, Chazaro I, Farrer LA, Baldwin CT, Gavras H, DeStefano AL: Genetic variants of WNK4 in whites and African Americans with hypertension. Hypertension 41: 1191-1195, 2003
59. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Connell JM, Webster J, Lathrop GM, Caulfield M, Munroe PB: Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Hum Mol Genet 14: 1805-1814, 2005